Chorionic villus sampling and amniocentesis: what are the risks in current practice?
- 1 April 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Obstetrics and Gynecology
- Vol. 15 (2) , 159-165
- https://doi.org/10.1097/00001703-200304000-00011
Abstract
Public demand for genetic counselling and prenatal diagnosis has increased during the past decade. As invasive diagnostic methods, such as chorionic villus sampling and amniocentesis, still have an important role to play in evaluating the fetus, one of the most important questions to address during genetic counselling is the procedure-related risk of these techniques. The possible factors modifying the specific risk of the actual fetus are discussed, together with factors that have an impact on procedure-related fetal loss and other complications. Risk factors regarding twin pregnancies, first and second-trimester chorionic villus sampling, early and mid-trimester amniocentesis are discussed separately. New developments have recently occurred in the laboratory techniques used in prenatal diagnosis. Their impact on genetic counselling and the employment of invasive techniques are also addressed. During genetic counselling, an individually tailored risk assessment needs to be established before any invasive procedure. This should take into account all the factors modifying the specific risk for aneuploidy or other disorders of the fetus, as well as the actual procedure-related risks.Keywords
This publication has 50 references indexed in Scilit:
- Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markersPrenatal Diagnosis, 2002
- Zur Komplikationsrate bei invasiven, intrauterinen Eingriffen an einer pränataldiagnostischen SchwerpunktabteilungUltraschall in der Medizin - European Journal of Ultrasound, 2002
- Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm deliveryAmerican Journal of Obstetrics and Gynecology, 2002
- An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm deliveryAmerican Journal of Obstetrics and Gynecology, 2001
- A single physician's experience with four thousand six hundred genetic amniocentesesAmerican Journal of Obstetrics and Gynecology, 2001
- Spontaneous fetal loss rates in a non-selected populationAmerican Journal of Medical Genetics, 2001
- Maternal age and fetal loss: population based register linkage studyBMJ, 2000
- Amniocentesis-Related Fetal Loss: A Cohort StudyObstetrics & Gynecology, 1998
- RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMENPublished by Elsevier ,1986
- CHROMOSOME ANALYSIS OF HUMAN AMNIOTIC-FLUID CELLSThe Lancet, 1966